How a 29-year old former hypochondriac built Sweden's most successful medtech startup

Excerpt

<div>Schildt, whose company last year raised a €20 million round from Europe's top investors including <b>Accel Partners</b> and Index Ventures, has big plans for the rest of the continent.Despite early resistance, his long-term goal is to revolutionize health care throughout the world. ”I believe the medical ...</div>